Cargando…
Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700049/ https://www.ncbi.nlm.nih.gov/pubmed/31098738 http://dx.doi.org/10.1007/s00277-019-03711-0 |
| _version_ | 1783444784224927744 |
|---|---|
| author | Nakamura, Fumihiko Nasu, Ryo |
| author_facet | Nakamura, Fumihiko Nasu, Ryo |
| author_sort | Nakamura, Fumihiko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6700049 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67000492019-08-29 Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia Nakamura, Fumihiko Nasu, Ryo Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2019-05-16 2019 /pmc/articles/PMC6700049/ /pubmed/31098738 http://dx.doi.org/10.1007/s00277-019-03711-0 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Nakamura, Fumihiko Nasu, Ryo Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia |
| title | Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia |
| title_full | Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia |
| title_fullStr | Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia |
| title_full_unstemmed | Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia |
| title_short | Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia |
| title_sort | prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700049/ https://www.ncbi.nlm.nih.gov/pubmed/31098738 http://dx.doi.org/10.1007/s00277-019-03711-0 |
| work_keys_str_mv | AT nakamurafumihiko prolongedsevereneutropeniaafterthefirstdaratumumabadministrationformultiplemyelomawithbaselineneutropenia AT nasuryo prolongedsevereneutropeniaafterthefirstdaratumumabadministrationformultiplemyelomawithbaselineneutropenia |